DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20212245

The effect of polycystic ovarian syndrome on the mental health of women of reproductive age

Oluwatoni D. Adebisi, Blessing C. Denwigwe-aggrey, Ashiat Bolanle Tairu, Ngozichukwu Ozoemena, Joy F. David, Esther Olunu Monday

Abstract


Polycystic ovary syndrome (PCOS) is defined as a hormonal disorder that is prevalent among women of reproductive age. It affects the metabolic, endocrine, and reproductive systems of the body as well as mental health. We compared up to 20 peer-reviewed literature that displayed the relationship between PCOS and mental health. We searched the PMC/NCBI/NIH database and we used the following keywords while searching the database: "polycystic ovarian syndrome" or "PCOS" and "mental health" or "depression" or "anxiety" or "low self-esteem" were included in the search for articles. Women of reproductive age are seen to be affected by PCOS. The effect of polycystic ovarian syndrome on the mental health of women of reproductive age has serious complications. Complications include an increased rate of anxiety and depression in the individual. When there is an increase in depression and anxiety, it tends to affect the physical changes and the confidence of women with PCOS. PCOS has been proven to be incurable but its symptoms can be managed. PCOS is linked with mental health and it has serious implications on the psychological health of the individual. Management of PCOS should include an early assessment of the patients’ mental health. If required, medications for mental health improvement should be prescribed in addition to medication for treating the physical and biochemical symptoms of PCOS.

 


Keywords


Hormonal disorder, Polycystic ovarian syndrome, Reproductive age, Mental health, PCOS, Depression

Full Text:

PDF

References


Scaruffi E, Gambineri A, Cattaneo S, Turra J, Vettor R, Mioni R. Personality and psychiatric disorders in women affected by polycystic ovary syndrome. Front Endocrinol. 2014;5:185.

Shakil M, Ashraf F, Wajid A. Sexual functioning as predictor of depressive symptoms and life satisfaction in females with Polycystic Ovary Syndrome (PCOS). Pak J Med Sci Q. 2020;36(7):1500-4.

Conte F, Banting L, Teede HJ, Stepto NK. Mental health and physical activity in women with polycystic ovary syndrome: a brief review. Sports Med. 2015;45(4):497-504.

Basirat Z, Faramarzi M, Esmaelzadeh S, Abedi Firoozjai SH, Mahouti T, Geraili Z. Stress, Depression, Sexual Function, and Alexithymia in Infertile Females with and without Polycystic Ovary Syndrome: A Case-Control Study. Int J Fertil Steril. 2019;13(3):203-8.

Shah K, Kulkarni R, Singh R, Pannu HS, Kamrai D. Role of Bupropion and Naltrexone in Managing Depression With Polycystic Ovary Syndrome: A Case Report and Literature Review. Cureus. 2020;12(11):11343.

Jiskoot G, Dietz de Loos A, Beerthuizen A, Timman R, Busschbach J, Laven J. Long-term effects of a three-component lifestyle intervention on emotional well-being in women with Polycystic Ovary Syndrome (PCOS): A secondary analysis of a randomized controlled trial. PLoS One. 2020;15(6):e0233876.

AlHussain F, AlRuthia Y, Al-Mandeel H, Bellahwal A, Alharbi F, Almogbel Y, et al. Metformin Improves the Depression Symptoms of Women with Polycystic Ovary Syndrome in a Lifestyle Modification Program. Patient Prefer Adherence. 2020;14:737-46.

Zhuang J, Wang X, Xu L, Wu T, Kang D. Antidepressants for polycystic ovary syndrome. Cochrane Database Syst Rev. 2013;(5):CD008575.

Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E, et al. American association of clinical endocrinologists, American college of endocrinology, and androgen excess and PCOS society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome--part 1. Endocr Pract. 2015;21(11):1291-300.

Fernandez R, Moore V, Van Ryswyk E, Varcoe T, Rodgers R, March W, et al. Sleep disturbances in women with polycystic ovary syndrome: prevalence, pathophysiology, impact and management strategies. Nat Sci Sleep. 2018;10:45-64.

ZareMobini F, Kazemi A, Farajzadegan Z. A comprehensive mental health care program for women with polycystic ovary syndrome: protocol for a mixed methods study. Reprod Health. 2018;15(1):46.

Balikci A, Erdem M, Keskin U, Bozkurt Zincir S, Gülsün M, Özçelik F, et al. Depression, Anxiety, and Anger in Patients with Polycystic Ovary Syndrome. Noro Psikiyatr Ars. 2014;51(4):328-33.

Sirmans SM, Pate KA. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol. 2013;6:1-13.

Witchel SF, Oberfield SE, Peña AS. Polycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment With Emphasis on Adolescent Girls. J Endocr Soc. 2019;3(8):1545-73.

Doretto L, Mari FC, Chaves AC. Polycystic Ovary Syndrome and Psychotic Disorder. Front Psychiatry. 2020;11:543.

Shaaban Z, Khoradmehr A, Jafarzadeh Shirazi MR, Tamadon A. Pathophysiological mechanisms of gonadotropins- and steroid hormones-related genes in etiology of polycystic ovary syndrome. Iran J Basic Med Sci. 2019;22(1):3-16.

Guo Q-J, Shan J, Xu Y-F, Hu Y-Y, Huo C-L, Song J-Y, et al. Pioglitazone Metformin Complex Improves Polycystic Ovary Syndrome Comorbid Psychological Distress via Inhibiting NLRP3 Inflammasome Activation: A Prospective Clinical Study. Mediators Inflamm. 2020;3050487.

Nandalike K, Strauss T, Agarwal C, Coupey SM, Sin S, Rajpathak S, et al. Screening for sleep-disordered breathing and excessive daytime sleepiness in adolescent girls with polycystic ovarian syndrome. J Pediatr. 2011;159(4):591-6.

Greenwood EA, Pasch LA, Cedars MI, Legro RS, Huddleston HG, Eunice Kennedy Shriver National Institute of Child Health and Human Development Reproductive Medicine Network. Association among depression, symptom experience, and quality of life in polycystic ovary syndrome. Am J Obstet Gynecol. 2018;219(3):279.

Blay SL, Aguiar JVA, Passos IC. Polycystic ovary syndrome and mental disorders: a systematic review and exploratory meta-analysis. Neuropsychiatr Dis Treat. 2016;12:2895-903.

Bazarganipour F, Ziaei S, Montazeri A, Foroozanfard F, Kazemnejad A, Faghihzadeh S. Psychological investigation in patients with polycystic ovary syndrome. Health Qual Life Outcomes. 2013;11:141.

Sanchez N. Suitability of the National Health Care Surveys to Examine Behavioral Health Services Associated with Polycystic Ovary Syndrome. J Behav Health Serv Res. 2018;45(2):252-68.

Banting LK, Gibson-Helm M, Polman R, Teede HJ, Stepto NK. Physical activity and mental health in women with polycystic ovary syndrome. BMC Womens Health. 2014;14(1):51.

Banting LK, Gibson-Helm M, Polman R, Teede HJ, Stepto NK. Physical activity and mental health in women with polycystic ovary syndrome. BMC Womens Health. 2014;14(1):51.